购物车
全部删除
您的购物车当前为空
别名 Tenapanor free base, RDX-5791, RDX5791, RDX 5791, AZD-1722, AZD1722, AZD 1722
Tenapanor (RDX 5791) 是钠氢离子交换NHE3的有效抑制剂, 对人和大鼠NHE3的IC50分别是5和10 nM。

Tenapanor (RDX 5791) 是钠氢离子交换NHE3的有效抑制剂, 对人和大鼠NHE3的IC50分别是5和10 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 313 | 现货 | |
| 5 mg | ¥ 745 | 现货 | |
| 10 mg | ¥ 1,180 | 现货 | |
| 25 mg | ¥ 2,380 | 现货 | |
| 50 mg | ¥ 3,550 | 现货 | |
| 100 mg | ¥ 4,950 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,490 | 现货 |
| 产品描述 | Tenapanor (RDX 5791) is an inhibitor of the sodium-proton (Na(+)/H(+)) exchanger NHE3, which plays a prominent role in sodium handling in the gastrointestinal tract and kidney. Tenapanor possesses an excellent preclinical safety profile and, as of now, there are no serious concerns about its side effects. |
| 靶点活性 | NHE3 (rat):10 nM (IC50), NHE3 (human):5 nM (IC50) |
| 别名 | Tenapanor free base, RDX-5791, RDX5791, RDX 5791, AZD-1722, AZD1722, AZD 1722 |
| 分子量 | 1145.05 |
| 分子式 | C50H66Cl4N8O10S2 |
| CAS No. | 1234423-95-0 |
| Smiles | CN1C[C@@H](c2cccc(c2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c2cccc(c2)[C@@H]2CN(C)Cc3c(Cl)cc(Cl)cc23)c2cc(Cl)cc(Cl)c2C1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 150 mg/mL (131 mM), Sonication is recommended. H2O: < 0.1 mg/mL (insoluble) | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (1.75 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多